Dr Xin Hui Chan 🕊
@xhschan
#Infection #GlobalHealth #Equity #Leadership • Academic Clinical Lecturer🦟🧫🦠🍄🪱💊💉• call me ‘Sin Hway’• she/her • views my own • retweets ≠ endorsements
1/n For half a millennium, quinine & structurally related antimalarials have been the mainstay of the treatment and prevention of malaria, the original fever from antiquity. Less well-known is their double-life as the first anti-arrhythmic drugs for heart rhythm abnormalities.

Great news for paediatric access to artemether-lumefantrine 🦟 💊 reuters.com/business/healt…
Our latest paper on immune signatures in dengue rdcu.be/euigj. Altered NK & T cells and blunted type I IFN responses discriminate patients who develop severe dengue @OUCRU_Programme @BristolUni @PKlenermanLab @CMMBristol @gregor_mi
Thank you to the British Infection Association for this blog feature. It was an immense - if unexpected - honour to have been awarded the Barnett Christie Prize Lecture 2024. Applications for 2025 are now open. Do consider applying if you're eligible. britishinfection.org/insights/bia-b…
📆 15 June is World Dengue Day 🦟 Dengue is the most important vector-borne viral infection in humans, with a record 14 million cases reported in 2024, but no licensed treatments to date 💊 @WHO are seeking feedback on target product profiles for treatments for non-severe and…
The @WHO as called for public consultations on target product profiles (TPPs) for treatments for non-severe and severe #dengue to support the ongoing clinical development of therapeutics approaching Phase 3 pivotal trials. @xhschan @DNDi @Novartis who.int/news-room/arti…
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients journals.lww.com/co-infectiousd…
☀️ On the cover of @TheLancetInfDis June issue in time for European arbovirus season, the @PREPARE_EUROPE MERMAIDS-Arbo doublebill of papers with commentary now in print - thank you! 🦟 Full issue: thelancet.com/journals/lanin… 🤒 Clinical outcomes: thelancet.com/journals/lanin… 🦠…
Predictors of Persistent Fever Among Patients With Suspected Infective Endocarditis: Think Outside the box bit.ly/3Sf0yTi
🏅Thank you, @OxfordMedSci and @TropMedOxford @NDMOxford for the news coverage on my work on drugs for vector-borne infections 🦟💊 @ESCMID @touchINFECTDIS tropicalmedicine.ox.ac.uk/news/oxford-cl…
It takes a village - thank you 🙏 Nick White @sarahlrj @bjangus Oxford University Clinical Academic Graduate School @OxfordMedSci @TropMedOxford @MORUBKK @OUCRU_Programme @Oxford_MRC_DTP @NDMOxford @UniofOxford @OUHospitals @NIHRresearch @UKRI_News @wellcometrust @WHO…
🌍 Meet Dr Xin Hui Chan – @ESCMID Young Investigator & touchINFECTIOUS DISEASES Future Leader 2025! 🏆 In this Q&A, she shares her journey, the power of collaboration, mentorship, and her take on the future of infectious disease control. 👉 touchinfectiousdiseases.com/insight/qa-wit… @xhschan
A packed #ESCMIDGlobal2025 #ESCMIDGlobal! So good to meet old friends and new from around the world in beautiful Vienna. Thank you @ESCMID for the Young Investigator Award and one of the best conferences I've ever attended. Well done Shanghavie Loganathan, Alice Scharmeli, and…




What a special Saturday night receiving the @ESCMID Young Investigator Award 2025 in Vienna 🇦🇹 from President Robert Skov at the #ESCMIDGlobal2025 #ESCMIDGlobal opening ceremony 🥇 Thank you @ESCMID for recognising a decade of work on drugs 💊 for tropical infections with many…


Looking forward to meeting many of you again at @ESCMID Global 2025 in Vienna, Austria later this week. Pleased to share our oral presentations and posters. With thanks to the fantastic resident doctors and senior co-authors for all their positive energy and teamwork in…

High consequence infectious disease cases in the UK between 1962 and 2023 - the definitive list, described in our latest paper: microbiologyresearch.org/content/journa… #HCID @HPRUezi @PSIOxford @RoyalFreeNHS